|
|
Volumn 1, Issue 10, 2002, Pages 821-825
|
|
Two decades of orphan product development
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGENTS ACTING ON THE EYE;
AGENTS ACTING ON THE GENITAL SYSTEM;
AGENTS USED IN EMERGENCY MEDICINE;
ALGLUCERASE;
ANALGESIC AGENT;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
CARDIOVASCULAR AGENT;
DERMATOLOGICAL AGENT;
DIAGNOSTIC AGENT;
GANCICLOVIR;
GASTROINTESTINAL AGENT;
GLUCOSYLCERAMIDASE;
HEMATOLOGIC AGENT;
IMMUNOLOGIC AGENT;
MONOCLONAL ANTIBODY;
ORPHAN DRUG;
PEGADEMASE;
RETROVIRUS VECTOR;
THALIDOMIDE;
URINARY TRACT AGENT;
VIRUS PROTEIN;
ARTICLE;
BIOTECHNOLOGY;
BIRTH DEFECT;
BRAIN TUMOR;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
ECONOMIC ASPECT;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
GENE THERAPY;
HERPES SIMPLEX VIRUS;
HUMAN;
LAW;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
UNITED STATES;
VIRAL GENE DELIVERY SYSTEM;
ANIMAL;
DRUG MANUFACTURE;
ECONOMICS;
LEGAL ASPECT;
METHODOLOGY;
PHARMACEUTICS;
REVIEW;
ANIMALS;
CLINICAL TRIALS;
HUMANS;
ORPHAN DRUG PRODUCTION;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 0036783342
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd919 Document Type: Article |
|
Times cited : (121)
|
|
References (7)
|
